Home » Posts tagged 'tal'

Tag Archives: tal

Quoted Micro 23 May 2016

ISDX

IMC Exploration (IMCP) has published its prospectus for the proposed switch to the standard list. The prospectus has been approved by the Central Bank of Ireland. The switch should happen by the end of May. At 1.5p (1p/2p) a share, IMC is valued at £1.6m.

 

St Mark Homes (SMAP) is trading at a discount of one-fifth to its NAV at the end of 2015. At 105p (90p/120p) a share, St Marks is valued at £3.1m, compared with the latest NAV of £3.95m. In 2015, pre-tax profit dipped from £579,000 to £549,000. The regional house builder has three projects in Surrey which will contribute to profit in 2016 and 2017, while the final two sales at Cheltenham were made earlier this year and there have been initial sales in Richmond. St Mark has already paid a dividend of 4.5p a share. Obtaining sufficient capital is difficult and it is holding back progress.

FT8 (GFT) has raised £173,000 at 0.7p a share in order to provide working capital following the news that a $1.5m finance package that was revealed last year has not become available. At 0.65p (0.6p/0.7p) a share, FT8, which was formerly Ezybonds, is valued at £4.8m. Last week, 65,000 shares were traded at 0.6p each – the first deal since March.

AIM

Seeing Machines (SEE) has signed a term sheet with a US investment fund which should mark the start of the process of spinning off the automotive technology operations of the company into a separate company, which will focus on the development of this technology. Seeing Machines will retain a significant stake. A product has already been provided to a customer and it will be in cars launched in 2018 – slightly later than hoped.

Greka Engineering & Technology Ltd (GEL), one of the spin offs from China-focused coal mine methane producer Golden Dragon Gas, plans to leave AIM. Trading in the shares of the s-making gas engineering and technology business has been limited since the spin off in September 2013. The board already has the backing of the owners of more than 75% of the shares so this will go ahead. Charles Stanley has been given the job of acquiring shares in the market at 0.8p each up until the quotation is cancelled.

Storm and waste water treatment equipment manufacturer Hydro International (HYD) has received a bid approach from major shareholder Hanover Investors. Hanover took a 17.5% stake in the middle of January and the share price has risen by one-third since then. The order book continued to grow in the first quarter, with orders in the North American wastewater market recovering. However, the orders will not contribute significantly until the second half of 2016.

HML Holdings (HML) has acquired Essex-based residential property lettings firm Homes & Watson Partnership for £360,000. The deal adds 1,400 units taking the group total to around 60,000. Trading is in line with expectations so pre-tax profit for the year to March 2016 should be £1.6m.

Karelian Diamond Resources (KDR) has raised £250,000 at 0.8p a share and this will help to fund development of the Lahtojoki diamond project. Each new share has a warrant attached that provides the opportunity to subscribe for another share at 1.6p each. They have to be exercised if the share price is at or above 5p for at least ten days.

TV and digital publishing company Ten Alps (TAL) has warned that recovery is taking much longer than expected. The television programme production business is doing well despite commissioning delays but publishing remains a problem area and it continues to lose money. The group loss for the year to June 2016 is likely to be lower than last year. Parts of the publishing division will be sold and the rest restructured.

Residential property developer Formation Group (FRM) fell into loss at the interim stage but there should be significant profits in the second half. There is £3.9m of profit share to come from the Norwich House development and there will be profit from the Iverson Road development. An interim profit was reported due to the writing back of a loan previously provided for but higher admin expenses meant that there was an operating loss. NAV rose from £7.6m to nearly £10m.

Latest edition of AIM Journal available here.

MAIN MARKET

North Midland Construction (NMD) continued to be profitable in the first quarter of this year having returned to profit in 2015. The order book for 2016 is around £200m with more to come from framework contracts. Only one costly legacy contract remains to be sorted out. The utilities division remains loss-making and existing contracts being reviewed. Civil engineering made a small first quarter profit. The main improvement came in the water-infrastructure business even though the latest AMP6 capital spending regulatory cycle is still building up. The main focus of the group is improving margins plus better cash collection.

 

ANDREW HORE

Daily Actions – UK Main & AIM markets 15032016

IntellisysLogoDaily summary analysis of changes in short term actions from our Daily Recs – AIM & Daily Recs Main markets reports

AIM Market

ST Rec. changed
From To
Basic Resources    
GCM Resources Buy Neutral
Goldstone Resources Neutral Buy
Jubilee Platinum Buy Neutral
Metals Exploration Buy Neutral
Paternoster Resources Buy Neutral
Financial Services    
ADVFN Buy Strong Buy
EKF Diagnostics Holdings Neutral Buy
Health Care    
Advanced Medical Solution Group Neutral Sell
Industrial Good & Services    
Accsys Technologies Neutral Buy
Dart Group Sell Neutral
Yolo Leisure & Technology Buy Neutral
Media    
Ten Alps Neutral Buy
Oil & Gas – Producers    
Baron Oil Neutral Buy
Personal & Household Goods    
Concha Buy Neutral
Retail    
Stanley Gibbons Group Buy Neutral
Technology    
On-Line Neutral Buy
Travel & Leisure    
Minoan Group Neutral Buy

Main Market

ST Rec. changed
From To
Insurance    
Novae Group Sell Neutral
Leisure & Hotels    
Intercontinental Hotels Group Neutral Sell
Life Assurance    
Aviva Sell Neutral

RISK WARNING

Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com

 

The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.

 

 

DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.

Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.

The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.

Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth.

Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors.

No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company.

Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise.

Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules.

Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance.

Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW.

 

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.